Healthcare Strategic Analysis of Indian Biosimilar Market

 

INDUSTRY
Healthcare

RELEASE DATE
10-May-2011
REGION
Asia Pacific
DELIVERABLE TYPE
Market Research

RESEARCH CODE
P43E-01-00-00-00
SKU
HC02321-AP-MR_08313
Yes
SHARE

Strategic Analysis of Indian Biosimilar Market
Published on: 10-May-2011 | SKU: HC02321-AP-MR_08313

Need more details?

$4,950.00

$3,712.50 save 25 %

DownloadLink
Need more details?

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.

Brief Summary of Indian Biosimilar Market

  • Executive Summary of the Biosimilar market
  • Future Impact

Overview of Global Biosimilar Market

  • Introduction to Biosimilars
  • Global Population Demographics
  • Key Biodrugs
  • Types of Products Manufactured by Major Participants
  • Market Size of Biosimilars: Global
  • Market Size: Biologic Patents Expiring in 2011-2016
  • Market Size: Biologics Patents Expiring 2016-2019
  • Market Size : Worldwide Sales of Key Biodrugs
  • Market Opportunities
  • Market Size of Biosimilars: Revenue Forecasts
  • Major Participants - Global
  • Major Participants - Trends

Overview if Indian Biosimilar Market

  • Overview of Indian Biosimilar Market
  • Timeline of Indian Market
  • Indian Market Portfolio
  • Domestic Market Potential
  • Market Drivers Ranked in Order of Impact
  • General Factors favoring the market
  • Market Restraints Ranked in Order of Impact
  • Hurdles faced by Indian Participants
  • Domestic Market Potential - Observed Trends in Market
  • Export Potential - Overview
  • Export Potential - Expansion Strategy of Indian Participants
  • Overview of Highly Regulated Markets: Europe
  • Overview of Highly Regulated Markets: The United States
  • Overview of Semi-regulated Markets: China
  • Cost Advantage of India
  • Biosimilar Market in India: Revenue Forecasts

Overview of Regulatory Scenario

  • Indian Regulations for Biosimilars
  • International Regulatory Authorities European Medicines Agency (EMA)
  • International Regulatory Authorities US-FDA

Overview of Major Participants in the Indian Market

  • Biocon
  • Dr. Reddy’s
  • Ranbaxy
  • Wockhardt
  • Intas Biopharmaceuticals
  • Shantha Biotech

Overview of Historical trends and Future Impact

  • 2001-2010: A Historical View of the Biosimilar Market
  • 2010-2015: Frost & Sullivan View on the Biosimilars Market

Overview of Chinese Biosimilar Market

  • Overview of Biosimilar Market in China
  • China – Major Participants

Frost and Sullivan: Overview

  • Who is Frost and Sullivan
  • What makes us unique
  • T.E.A.M. Methodology
  • Global Perspective

Have questions about this research or need deeper insights?
Speak directly with our analytics experts for tailored recommendations.

Recent related Healthcare research

07 Sep 2026   |   Global   |   Technology Research

Synthetic Antibodies and AI-Optimized Immunotherapies

Artificial intelligence is becoming increasingly relevant to antibody discovery and immunotherapy development, supporting target identification, de novo antibody design, antibody engineering, clinical intelligence, and bioprocessing. Advances in generative AI, protein language models, diffusion mode...

28 Aug 2026   |   Global   |   Technology Research

Innovations and Growth Opportunities in Advanced Medical Devices, Artificial Intelligence Solutions, Digital Solutions, and Medical Imaging Solutions

The latest issue of Advanced MedTech Technology Opportunity Engine (TOE) spotlights a diverse slate of innovations across advanced medical devices, artificial intelligence solutions, digital solutions, and medical imaging solutions.The issue features advanced medical devices such as active bioelectr...

27 Aug 2026   |   Global   |   Frost Radar

Frost Radar: AI-Powered Molecular Diagnostics, 2026

AI-powered molecular diagnostics is an emerging and moderately fragmented industry that includes molecular diagnostics companies, precision medicine platforms, sequencing specialists, AI-driven analytics providers, and disease-focused biotechnology companies. No single company has dominated, present...

26 Aug 2026   |   Global   |   Technology Research

Growth Opportunities and Advancements in Acute and Chronic Wound Care

A wound is any disruption in the normal structure and function of the skin or underlying tissues. It can result from physical injury, surgery, or underlying medical conditions. Wounds are broadly classified into two categories: acute wounds and chronic wounds. Acute wounds typically heal through the...

26 Aug 2026   |   Global   |   Frost Radar

Frost Radar™: Healthcare Infrastructure Cybersecurity in the United States, 2026

Healthcare organizations are expanding their digital environments across cloud infrastructure, connected medical devices, applications, identities, operational technology, and distributed care settings, creating a broader and increasingly interconnected attack surface. Cybersecurity is, therefore, e...

 

Purchase includes:
  • Report download
  • Growth Dialog™ with our experts

Growth Dialog™

A tailored session with you where we identify the:
  • Strategic Imperatives
  • Growth Opportunities
  • Best Practices
  • Companies to Action

Impacting your company's future growth potential.

This research deliverable provides deep insights into the Biosimilar market in India. It also includes an overview of the Indian regulatory and R&D process briefing about the biosimilars, trends in regional/local pharmaceutical and biotechnology development as well as the impact of those developments. The research deliverable also covers the overview of the other major biosimilar players like China. The research service also gives a deeper insight into the profiles of the companies that are into this segment in India. It also covers the historical trends and future impacts on Biosimilar Markets.
More Information
Deliverable Type Market Research
No Index No
Podcast No
Industries Healthcare
WIP Number P43E-01-00-00-00
Is Prebook No

Strategic Analysis of Indian Biosimilar Market

$4,950.00

Special Price $3,712.50 save 25 %

In stock
SKU
HC02321-AP-MR_08313